The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)

John R. Johnson

Division of Oncology Drug Products (HFD-150)

Center for Drug Evaluation and Research

United States Food and Drug Administration




Name/email consistency: high



  • Division of Oncology Drug Products (HFD-150), Center for Drug Evaluation and Research, United States Food and Drug Administration, Rockville, USA. 2003 - 2005


  1. Approval summary for erlotinib for treatment of patients with locally advanced or metastatic non-small cell lung cancer after failure of at least one prior chemotherapy regimen. Johnson, J.R., Cohen, M., Sridhara, R., Chen, Y.F., Williams, G.M., Duan, J., Gobburu, J., Booth, B., Benson, K., Leighton, J., Hsieh, L.S., Chidambaram, N., Zimmerman, P., Pazdur, R. Clin. Cancer Res. (2005) [Pubmed]
  2. End points and United States Food and Drug Administration approval of oncology drugs. Johnson, J.R., Williams, G., Pazdur, R. J. Clin. Oncol. (2003) [Pubmed]
  3. Approval summary: imatinib mesylate capsules for treatment of adult patients with newly diagnosed philadelphia chromosome-positive chronic myelogenous leukemia in chronic phase. Johnson, J.R., Bross, P., Cohen, M., Rothmann, M., Chen, G., Zajicek, A., Gobburu, J., Rahman, A., Staten, A., Pazdur, R. Clin. Cancer Res. (2003) [Pubmed]
WikiGenes - Universities